The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
Jake Mintz and Jordan Shusterman dig into what is going wrong with the Yankees, who was selected as an All-Star starter and ...
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
There’s no cure for Alzheimer’s disease, but in the past few years, researchers have found treatments that seem to stop some ...
Lilly’s drug that can slow Alzheimer’s disease has received the approval of the U.S. Food and Drug Administration; the ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
I’m so excited that we have something that actually possibly could lead to a cure. There is no cure yet. But we’re really ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The Food and Drug Administration (FDA) on Tuesday approved donanemab, Eli Lilly’s monoclonal antibody drug for early-stage ...